LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Decision (EU) 2018/134 of 24 January 2018 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2018) 218) (Text with EEA relevance. )

Commission Implementing Decision (EU) 2018/134 of 24 January 2018 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2018) 218) (Text with EEA relevance. )

Implementing Decision (EU) 2018/134 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annexes I and II to Decision 2008/911/EC are amended in accordance with the Annex to this Decision.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Decision 2008/911/EC is amended as follows: (1) In Annex I, the following substance is inserted after Pimpinella anisum L: ‘ Sideritis scardica Griseb., herba.’; (2) In Annex II, the following is inserted after the COMMUNITY LIST ENTRY on Pimpinella anisum L: ‘UNION LIST ENTRY ON SIDERITIS SCARDIA GRISEB., HERBA Scientific name of the plant Sideritis scardica Griseb. Botanical family Lamiaceae (Labiatae) Herbal substance Ironwort ( Sideritis herba ) Common name in all EU official languages of herbal preparation BG (bălgarski): Мурсалски чай, стрък CS (čeština): nať hojníku DA (dansk): Kortkroneurt DE (Deutsch): Balkan-Gliedkraut EL (elliniká): Πόα σιδηρίτου EN (English): Ironwort ES (español): Siderita, partes aéreas de ET (eesti keel): haavarohuürt FI (suomi): raudakki, verso FR (français): Crapaudine (parties aériennes de) HR (hrvatska): očistova zelen HU (magyar): sármányvirág virágos hajtása IT (italiano): Stregonia parti aeree fiorite LT (lietuvių kalba): Timsrų žolė LV (latviešu valoda): Siderītu laksts MT (Malti): ħaxixa tas-Sideritis NL (Nederlands): (Griekse) bergthee, kruid PL (polski): Ziele gojnika PT (português): Siderite, partes aéreas RO (română): iarba de ceaiul muntelui cretan SK (slovenčina): Vňať ránhoja SL (slovenščina): zel sklepnjaka SV (svenska): Sårmynta, ört IS (íslenska): NO (norsk): Gresk fjellte Herbal preparations Comminuted herbal substance European Pharmacopoeia monograph reference Not applicable Indications Indication (1) Traditional herbal medicinal product used for the relief of cough associated with cold. Indication (2) Traditional herbal medicinal product used for the relief of mild gastrointestinal discomfort. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology”. Specified posology Adults and elderly Indication (1) and (2) Single dose: Herbal tea: 2-4 g of the comminuted herbal substance in 150-200 ml of water as a herbal infusion 2-3 times daily Daily dose: up to 12 g The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”) Route of administration Oral use Duration of use or any restrictions on the duration of use Indication (1) If symptoms persist longer than 1 week during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Indication (2) If symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substance and to other plants of the Lamiaceae (Labiatae) family. Special warnings and precautions for use The use in children and adolescents under 18 years of age has not been established due to lack of adequate data. If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Interactions with other medicinal products and other forms of interaction None reported Fertility, pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, use during pregnancy and lactation is not recommended. No fertility data available. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects None known If adverse reactions occur, a doctor or qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. Pharmaceutical particulars (if necessary) Not applicable Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product) Not applicable.’

Other acts of the same type
Commission Implementing Decision (EU) 2026/1559 of 10 July 2026 laying down rules for the application of Directive (EU) 2016/797 of the European Parliament and of the Council as regards a request from Italy not to apply the table of priority of trackside supported levels set out in Commission Implementing Regulation (EU) 2023/1695 (notified under document C(2026) 4714)Commission Decision (EU) 2026/1701 of 10 July 2026 confirming the participation of Hungary in the enhanced cooperation on the establishment of the European Public Prosecutor’s OfficeCouncil Decision (CFSP) 2026/1704 of 10 July 2026 in support of the implementation of United Nations Security Council Resolution 1540 (2004) on the non-proliferation of weapons of mass destruction and their means of delivery to non-State actorsCouncil Implementing Decision (EU) 2026/1725 of 10 July 2026 authorising the provision of support from the EU Cybersecurity Reserve to the Republic of Moldova (Text with EEA relevance)Council Implementing Decision (EU) 2026/1728 of 10 July 2026 amending Implementing Decision (EU) 2017/784 authorising the Italian Republic to apply a special measure derogating from Articles 206 and 226 of Directive 2006/112/EC on the common system of value added taxCouncil Decision (CFSP) 2026/1729 of 10 July 2026 in support of a zone free of weapons of mass destruction in the Middle East (ME WMDFZ) in a dynamic regional security environmentCouncil Implementing Decision (EU) 2026/1733 of 10 July 2026 suspending the application of certain provisions of Regulation (EC) No 810/2009 of the European Parliament and of the Council in respect of GuineaCouncil Decision (EU) 2026/1758 of 10 July 2026 on the existence of an excessive deficit in BulgariaCouncil Decision (EU) 2026/1771 of 10 July 2026 on the termination of the Voluntary Partnership Agreement between the European Union and the Republic of Liberia on forest law enforcement, governance and trade in timber products to the European UnionCouncil Implementing Decision (EU) 2026/1775 of 10 July 2026 authorising Croatia to apply reduced rates of excise duty to gas oil and unleaded petrol used as motor fuels, pursuant to Article 19 of Directive 2003/96/ECCouncil Implementing Decision (EU) 2026/1776 of 10 July 2026 authorising Belgium to apply a reduced rate of taxation to electricity directly supplied to vessels berthed in ports, in accordance with Article 19 of Directive 2003/96/ECCouncil Decision (EU) 2026/1953 of 10 July 2026 on the conclusion, on behalf of the Union, of the Agreement in the form of an Exchange of Letters between the European Union and the Islamic Republic of Pakistan pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom’s withdrawal from the European Union

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next